Evidence map›Paper›PMID 32571282›Full record

ArticleBMC musculoskeletal disorders2020

Treatment effects of reverse total shoulder arthroplasty - a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient.

Joerg Huber, Ulrich Irlenbusch, Max J Kääb, Falk Reuther, Georges Kohut, Andy Judge

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC musculoskeletal disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Glenosphere Tilt and Size Predict Shoulder Kinematics During the Hand-to-Back Motion After Reverse Shoulder Arthroplasty.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2025
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Joerg HuberDepartment of Orthopedics, Stadtspital Triemli, Birmensdorferstr. 497, 8063, Zurich, CH, Switzerland. joerg.huber2@triemli.zuerich.ch.ORCID http://orcid.org/0000-0002-1413-1314
Ulrich IrlenbuschOrthopedic Clinics, Marienstift, Wachsenburgallee 12, D 99310, Arnstadt, Germany.
Max J KääbSportorthopädicum Straubing, Bahnhofplatz 27, D 94315, Straubing, Germany.
Falk ReutherDRK Kliniken Köpenick, Salvador-Allende-Strasse 2-8, D 12559, Berlin, Germany.
Georges KohutClinique generale, Rue Hans Geiler 6, 1700, Fribourg, CH, Switzerland.
Andy JudgeMusculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Learning & Research Building, Southmead Hospital, Bristol, BS10 5NB, UK.
DRK Kliniken Berlin · DEGénérale-Beaulieu Clinic · CHSouthmead Hospital · GBStadtwerke Straubing (Germany) · DETriemli Hospital · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough shoulder arthroplasty is less common than knee or hip arthroplasty, the number of procedures being performed is increasing rapidly. The treatment effect is a simple method to measure outcome of joint replacement. The method was applied to measure results of total hip/knee arthroplasty but not yet for shoulder arthroplasty.

methodsIncluded were patients with unilateral cuff arthropathy (Hamada grades > = 2) treated with reversed total shoulder arthroplasty (RSA) in this prospective multicenter study. The patients were assessed with the ASES questionnaire. The treatment effects (TE) was calculated for each patient. TE = score reduction/baseline score. A positive TE means amelioration, TE = 0 unchanged, and a negative TE means worse. The primary aim was to calculate the TE's for RSA at 6, 12, 24, and 60 months postoperatively. The secondary aim was to analyze the influence of confounders (preoperative Hamada grade, age, gender, dominance, side of the affected shoulder, general co-morbidities measured using ASA grade).

resultsTwo hundred three patients were included for this analysis of whom 183 patients had a complete 2 year follow up. Two years postoperatively the mean ASES score augmented significant from 20.5 to 78.7 (p < 0.001). The 2 year TE's ranged from 1 to 0.09. We had no patient with a negative TE. A higher Hamada grade was associated with better TE's (Hamada grade 4+ vs. 2, p-value 0.042). For age and dominant side there were weak associations where those aged 80+ and dominant side had better TE's. The patients with higher ASA grade had lower TE's (ASA grade 4+ vs. 1, p-value 0.013). The mean TE's were 0.77 at 6-months, 0.81 at 1 year, 0.76 at 2 years and 0.73 at 5 years.

conclusionsThe outcome for reverse shoulder arthroplasty can be measured with the treatment effect method; the 2 years TE's vary from 1 to 0.09. The mean treatment effects change little in the first five postoperative years (from 0.73 to 0.81). The confounders for better TE's were: higher severity of cuff arthropathy (Hamada grade 3, 4 and 5), less co-morbidities (ASA Grade 1), higher age (80+) and dominant side. Gender did not influence the 2-year TE's.

trial registrationComité intercantonal d'éthique (Jura, Fribourg, Neuchâtel), number 01/2008, 24.09.2008.

Indexed as

Arthroplasty, Replacement, ShoulderHealth Status IndicatorsSurveys and QuestionnairesAdultAgedAged, 80 and overEuropeFemaleHealth StatusHumansLinear ModelsMaleMiddle AgedPredictive Value of TestsProspective StudiesRecovery of FunctionConfoundersCuff arthropathyOutcomeReverse shoulder arthroplastyTreatment effect

Identifiers

PMID32571282
PMCPMC7310507
OpenAlexW3036328869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.